FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119120854> ?p ?o ?g. }

• W3119120854 abstract "An orally active follicle stimulating hormone receptor allosteric agonist would provide a preferred treatment for over 16 million infertile women of reproductive age in low complexity methods (ovulation induction-intrauterine insemination) or in high complexity methods (controlled ovarian stimulation- in vitro fertilization). We present two oral follicle stimulating hormone receptor allosteric agonist compounds that have the desired pharmacology, drug metabolism, pharmacokinetics, and safety profile for clinical use. These molecules provide a single agent suitable for ovulation induction-intrauterine insemination or controlled ovarian stimulation- in vitro fertilization that is more convenient for patients and achieves similar preclinical efficacy as rec-hFSH. TOP5668, TOP5300 were evaluated in vitro in Chinese hamster ovary cells transfected with individual glycoprotein receptors measuring cAMP (FSHR, LH/CGR, thyroid stimulating hormone receptor). TOP5668 was found to have solely follicle stimulating hormone receptor allosteric agonist activity while TOP5300 was found to have mixed follicle stimulating hormone receptor allosteric agonist and LHR-AA activity. Both compounds stimulated concentration-dependent increases in estradiol production from cultured rat granulosa cells in the presence or absence of low dose rec-hFSH, while only TOP5300 stimulated testosterone production from rat primary Leydig cells. In pooled human granulosa cells obtained from patients undergoing controlled ovarian stimulation- in vitro fertilization, TOP5300 stimulated 7-fold greater maximal estradiol response than rec-hFSH and TOP5668 was 10-fold more potent than TOP5300. Both TOP5300 and TOP5668 stimulated follicular development in immature rat to the same efficacy as recombinant follicle stimulating hormone. In mice treated with TOP5300, in the presence of low dose of follicle stimulating hormone, there were no differences in oocyte number, fertilization rate, and hatched blastocyst rate in mice with TOP5300 and low dose follicle stimulating hormone vs. reference proteins pregnant mare serum gonadotropin or high dose rec-hFSH. ADME/PK and safety profiles were favorable. In addition, there was no appreciable activity on thyroid hormones by TOP5300 in 14-days toxicological study in rat or dog. The selected lead compound, TOP5300 stimulated a more robust increase in estradiol production from granulosa-lutein cells from women with polycystic ovarian syndrome patient compared to rec-hFSH. Conclusions: Two novel oral FSHR allosteric agonist, TOP5668 and TOP5300, were found to mimic the biological activity of rec hFSH in preclinical studies. Both compounds led to folliculogenesis and superovulation in rat and mice. Specifically, TOP5300 led to a similar number of ovulated oocytes that fertilized and developed into hatched blastocysts in mice when compared to rec-hFSH. The safety profile demonstrated lack of toxicity." @default.
• W3119120854 created "2021-01-18" @default.
• W3119120854 creator A5036712642 @default.
• W3119120854 creator A5038619483 @default.
• W3119120854 creator A5056914488 @default.
• W3119120854 creator A5073265550 @default.
• W3119120854 date "2021-01-14" @default.
• W3119120854 modified "2023-10-12" @default.
• W3119120854 title "Discovery and Preclinical Development of Orally Active Small Molecules that Exhibit Highly Selective Follicle Stimulating Hormone Receptor Agonism" @default.
• W3119120854 cites W12355438 @default.
• W3119120854 cites W1776304226 @default.
• W3119120854 cites W1896007456 @default.
• W3119120854 cites W1964079441 @default.
• W3119120854 cites W1972613457 @default.
• W3119120854 cites W1973393731 @default.
• W3119120854 cites W1981825725 @default.
• W3119120854 cites W1985116028 @default.
• W3119120854 cites W1987898157 @default.
• W3119120854 cites W1990477940 @default.
• W3119120854 cites W1991100951 @default.
• W3119120854 cites W2002369636 @default.
• W3119120854 cites W2002438902 @default.
• W3119120854 cites W2004820795 @default.
• W3119120854 cites W2005678694 @default.
• W3119120854 cites W2020881511 @default.
• W3119120854 cites W2046826218 @default.
• W3119120854 cites W2048800048 @default.
• W3119120854 cites W2050527917 @default.
• W3119120854 cites W2055015023 @default.
• W3119120854 cites W2055591390 @default.
• W3119120854 cites W2065157599 @default.
• W3119120854 cites W2077223663 @default.
• W3119120854 cites W2080718381 @default.
• W3119120854 cites W2086102836 @default.
• W3119120854 cites W2093776465 @default.
• W3119120854 cites W2094730776 @default.
• W3119120854 cites W2102459914 @default.
• W3119120854 cites W2102679211 @default.
• W3119120854 cites W2106037345 @default.
• W3119120854 cites W2111806670 @default.
• W3119120854 cites W2128764402 @default.
• W3119120854 cites W2129979629 @default.
• W3119120854 cites W2132745308 @default.
• W3119120854 cites W2141675873 @default.
• W3119120854 cites W2149600127 @default.
• W3119120854 cites W2150925510 @default.
• W3119120854 cites W2164074861 @default.
• W3119120854 cites W2231147516 @default.
• W3119120854 cites W2336043969 @default.
• W3119120854 cites W2462894306 @default.
• W3119120854 cites W2607697627 @default.
• W3119120854 cites W2677028763 @default.
• W3119120854 cites W2799891393 @default.
• W3119120854 cites W2804403323 @default.
• W3119120854 cites W2808243086 @default.
• W3119120854 cites W2890049649 @default.
• W3119120854 cites W2894521341 @default.
• W3119120854 cites W2896950650 @default.
• W3119120854 cites W2903913221 @default.
• W3119120854 cites W2921051332 @default.
• W3119120854 cites W2928606974 @default.
• W3119120854 cites W2944926562 @default.
• W3119120854 cites W2957309593 @default.
• W3119120854 cites W2985033855 @default.
• W3119120854 cites W3046924565 @default.
• W3119120854 cites W3110630596 @default.
• W3119120854 cites W4241434933 @default.
• W3119120854 cites W4248728823 @default.
• W3119120854 cites W4256605237 @default.
• W3119120854 doi "https://doi.org/10.3389/fphar.2020.602593" @default.
• W3119120854 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7845544" @default.
• W3119120854 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33519465" @default.
• W3119120854 hasPublicationYear "2021" @default.
• W3119120854 type Work @default.
• W3119120854 sameAs 3119120854 @default.
• W3119120854 citedByCount "5" @default.
• W3119120854 countsByYear W31191208542021 @default.
• W3119120854 countsByYear W31191208542022 @default.
• W3119120854 countsByYear W31191208542023 @default.
• W3119120854 crossrefType "journal-article" @default.
• W3119120854 hasAuthorship W3119120854A5036712642 @default.
• W3119120854 hasAuthorship W3119120854A5038619483 @default.
• W3119120854 hasAuthorship W3119120854A5056914488 @default.
• W3119120854 hasAuthorship W3119120854A5073265550 @default.
• W3119120854 hasBestOaLocation W31191208541 @default.
• W3119120854 hasConcept C121608353 @default.
• W3119120854 hasConcept C126322002 @default.
• W3119120854 hasConcept C134018914 @default.
• W3119120854 hasConcept C170493617 @default.
• W3119120854 hasConcept C23589133 @default.
• W3119120854 hasConcept C2777702977 @default.
• W3119120854 hasConcept C2778575703 @default.
• W3119120854 hasConcept C2778938600 @default.
• W3119120854 hasConcept C2779279165 @default.
• W3119120854 hasConcept C2780536345 @default.
• W3119120854 hasConcept C2781230225 @default.
• W3119120854 hasConcept C29390026 @default.
• W3119120854 hasConcept C530470458 @default.
• W3119120854 hasConcept C71315377 @default.
• W3119120854 hasConcept C71924100 @default.

• next